Matches in Nanopublications for { ?s ?p "DDI between Eszopiclone and Triprolidine - The CNS depressants, Triprolidine and Eszopiclone, may increase adverse/toxic effects due to additivity. Monitor for increased CNS depressant effects during concomitant therapy. [drugbank_resource:DB00402_DB00427]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00402_DB00427 label "DDI between Eszopiclone and Triprolidine - The CNS depressants, Triprolidine and Eszopiclone, may increase adverse/toxic effects due to additivity. Monitor for increased CNS depressant effects during concomitant therapy. [drugbank_resource:DB00402_DB00427]" assertion.